"Clinical use of drotrecogin alfa (activated): Patients treated in the XEUS study differ from high risk prowess patients" by Jay Steingrub, MD

Selected Works of Jay Steingrub MD

Follow Contact

Article

Clinical use of drotrecogin alfa (activated): Patients treated in the XEUS study differ from high risk prowess patients

All Scholarly Works

Jay Steingrub, MD, Baystate Health

Document Type

Presentations, Research

Publication Date

10-1-2004

Citation Information

Rickert T, Steingrub JS, Cheatham M, Safcsak K, Lipsetts P, Effron M, Linde-Zwirble W, Zeckel M. Clinical use of drotrecogin alfa (activated): Patients treated in the XEUS study differ from high risk prowess patients. Chest 2004. Seattle, WA. Oct 23-Oct 28, 2004.